Semaglutide

Semaglutide is a GLP-1 receptor agonist available as a once-weekly injection.

$ 120.00 USD
Buy now

Research Overview

Key Benefits

  1. Weight Loss
    • Clinical trials show 10–15% average body weight reduction with long-term use for obesity.
    • Reduces appetite and increases satiety, making it easier to maintain calorie deficits.
  2. Blood Sugar Control
    • Lowers HbA1c by up to ~1.5–2% in type 2 diabetes.
    • Improves fasting and post-meal glucose.
  3. Cardiovascular Protection
    • Proven to reduce risk of major cardiovascular events (heart attack, stroke, CV death) in adults with type 2 diabetes and established heart disease.

Important Notes

  • Not for people with a personal/family history of medullary thyroid carcinoma or MEN-2.
  • Must be paired with lifestyle changes for best results.